LPL Financial’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $601K | Buy |
|
|||||
|
2025
Q1 | $482K | Buy |
|
|||||
|
2024
Q4 | $489K | Buy |
|
|||||
|
2024
Q3 | $460K | Buy |
|
|||||
|
2024
Q2 | $343K | Buy |
|
|||||
|
2024
Q1 | $303K | Buy |
|
|||||
|
2023
Q4 | $215K | Sell |
|
|||||
|
2023
Q3 | $259K | Buy |
|
|||||
|
2023
Q2 | $252K | Sell |
|
|||||
|
2023
Q1 | $473K | Buy |
|
|||||
|
2022
Q4 | $358K | Buy |
|
|||||
|
2022
Q3 | $293K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $238K | Buy |
|